A Case of Drug Reaction With Eosinophilia and Systemic Symptoms Caused by Mitotane: A Cytotoxic Drug Treating Adrenocortical Carcinoma
Dermatitis. 2024 Apr 8. doi: 10.1089/derm.2023.0325. Online ahead of print.NO ABSTRACTPMID:38593446 | DOI:10.1089/derm.2023.0325 (Source: Dermatitis)
Source: Dermatitis - April 9, 2024 Category: Dermatology Authors: Jinxin Qi Qian Zhang Xian Jiang Source Type: research
Reactions to Pramoxine, Our Experience from 2020 to 2023
Dermatitis. 2024 Apr 8. doi: 10.1089/derm.2024.0062. Online ahead of print.NO ABSTRACTPMID:38593447 | DOI:10.1089/derm.2024.0062 (Source: Dermatitis)
Source: Dermatitis - April 9, 2024 Category: Dermatology Authors: Caroline Brumley Puneet Arora Anne Neeley Source Type: research
Nonmedical Adhesive Allergens: Retrospective Analysis of Cross-Sectional Data From the North American Contact Dermatitis Group, 2001-2018
Dermatitis. 2024 Apr 8. doi: 10.1089/derm.2023.0134. Online ahead of print.NO ABSTRACTPMID:38593448 | DOI:10.1089/derm.2023.0134 (Source: Dermatitis)
Source: Dermatitis - April 9, 2024 Category: Dermatology Authors: Amber Reck Atwater Raina Bembry Cynthia L Green Erin M Warshaw Donald V Belsito Joel G DeKoven Margo J Reeder Jonathan I Silverberg James S Taylor Vincent A DeLeo Denis Sasseville Melanie D Pratt Kathryn A Zug Cory Dunnick Marie-Claude Houle Source Type: research
Amiodarone-Induced Psoriasiform Dermatitis
Ann Pharmacother. 2024 Apr 8:10600280241244511. doi: 10.1177/10600280241244511. Online ahead of print.NO ABSTRACTPMID:38590149 | DOI:10.1177/10600280241244511 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 9, 2024 Category: Drugs & Pharmacology Authors: Myriam Agrebi Dhouha Sahnoun Najet Ghariani Mohamed Denguezli Chaker Ben Salem Source Type: research
Dupilumab in patients with atopic dermatitis: assessing treatment response, clinical features and potential biomarkers in real-life
Conclusions. In this cohort, none of the evaluated biomarkers at baseline were associated with a better/earlier clinical response to dupilumab. Dupilumab treatment for 52 weeks resulted in a significant and sustained reduction in blood levels of total IgE and allergen-specific IgE to aeroallergens. The potential long-term clinical benefit of these effects, even after discontinuing dupilumab therapy in patients with AD, should be explored to a greater extent.PMID:38591168 | DOI:10.23822/EurAnnACI.1764-1489.341 (Source: European Annals of Allergy and Clinical Immunology)
Source: European Annals of Allergy and Clinical Immunology - April 9, 2024 Category: Allergy & Immunology Authors: R Lim ão R Br ás E Pedro S L Silva A Lopes Source Type: research
Effect of Mixed Probiotics on Ovalbumin-Induced Atopic Dermatitis in Juvenile Mice
In this study, we aimed to assess the effectiveness of mixed probiotics as a treatment option for atopic dermatitis induced by ovalbumin. BALB/c juvenile mice were classified and divided into the ovalbumin group, mixed probiotic group (ovalbumin + LK), and control group. Except for the control group, all mice were sensitized with ovalbumin to establish a model of atopic dermatitis. The mixed probiotics were given by gavage for 14 days. Mice body weight, skin lesions, skin inflammation, ovalbumin-specific Ig, the number of Treg and CD103+DC, and the expression level of PD-1/PD-L1 were examined. The results showed that mixed...
Source: International Journal of Microbiology - April 9, 2024 Category: Microbiology Authors: Jinli Huang Xingzhi Wang Qiuhong Li Panpan Zhang Zenghui Jing Juan Zhang Hui Su Xin Sun Source Type: research
Reactions to Pramoxine, Our Experience from 2020 to 2023
Dermatitis. 2024 Apr 8. doi: 10.1089/derm.2024.0062. Online ahead of print.NO ABSTRACTPMID:38593447 | DOI:10.1089/derm.2024.0062 (Source: Dermatitis)
Source: Dermatitis - April 9, 2024 Category: Dermatology Authors: Caroline Brumley Puneet Arora Anne Neeley Source Type: research
A Case of Drug Reaction With Eosinophilia and Systemic Symptoms Caused by Mitotane: A Cytotoxic Drug Treating Adrenocortical Carcinoma
Dermatitis. 2024 Apr 8. doi: 10.1089/derm.2023.0325. Online ahead of print.NO ABSTRACTPMID:38593446 | DOI:10.1089/derm.2023.0325 (Source: Dermatitis)
Source: Dermatitis - April 9, 2024 Category: Dermatology Authors: Jinxin Qi Qian Zhang Xian Jiang Source Type: research
Nonmedical Adhesive Allergens: Retrospective Analysis of Cross-Sectional Data From the North American Contact Dermatitis Group, 2001-2018
Dermatitis. 2024 Apr 8. doi: 10.1089/derm.2023.0134. Online ahead of print.NO ABSTRACTPMID:38593448 | DOI:10.1089/derm.2023.0134 (Source: Dermatitis)
Source: Dermatitis - April 9, 2024 Category: Dermatology Authors: Amber Reck Atwater Raina Bembry Cynthia L Green Erin M Warshaw Donald V Belsito Joel G DeKoven Margo J Reeder Jonathan I Silverberg James S Taylor Vincent A DeLeo Denis Sasseville Melanie D Pratt Kathryn A Zug Cory Dunnick Marie-Claude Houle Source Type: research
Amiodarone-Induced Psoriasiform Dermatitis
Ann Pharmacother. 2024 Apr 8:10600280241244511. doi: 10.1177/10600280241244511. Online ahead of print.NO ABSTRACTPMID:38590149 | DOI:10.1177/10600280241244511 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 9, 2024 Category: Drugs & Pharmacology Authors: Myriam Agrebi Dhouha Sahnoun Najet Ghariani Mohamed Denguezli Chaker Ben Salem Source Type: research
Evaluating the clinical utility of the Atopic Dermatitis Control Tool: measurement properties and agreement between patients' responses and clinicians' impressions of atopic dermatitis control
Br J Dermatol. 2024 Apr 9:ljae056. doi: 10.1093/bjd/ljae056. Online ahead of print.NO ABSTRACTPMID:38593196 | DOI:10.1093/bjd/ljae056 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - April 9, 2024 Category: Dermatology Authors: Eric L Simpson Laurent Eckert Abhijit Gadkari T Michelle Brown Peter A Lio Benjamin Lockshin Lauren Nelson Sheri E Fehnel Puneet Mahajan Jingdong Chao Michaela Nyg årdas Isabelle Guillemin Source Type: research
Dupilumab in patients with atopic dermatitis: assessing treatment response, clinical features and potential biomarkers in real-life
Conclusions. In this cohort, none of the evaluated biomarkers at baseline were associated with a better/earlier clinical response to dupilumab. Dupilumab treatment for 52 weeks resulted in a significant and sustained reduction in blood levels of total IgE and allergen-specific IgE to aeroallergens. The potential long-term clinical benefit of these effects, even after discontinuing dupilumab therapy in patients with AD, should be explored to a greater extent.PMID:38591168 | DOI:10.23822/EurAnnACI.1764-1489.341 (Source: European Annals of Allergy and Clinical Immunology)
Source: European Annals of Allergy and Clinical Immunology - April 9, 2024 Category: Allergy & Immunology Authors: R Lim ão R Br ás E Pedro S L Silva A Lopes Source Type: research
Effect of Mixed Probiotics on Ovalbumin-Induced Atopic Dermatitis in Juvenile Mice
In this study, we aimed to assess the effectiveness of mixed probiotics as a treatment option for atopic dermatitis induced by ovalbumin. BALB/c juvenile mice were classified and divided into the ovalbumin group, mixed probiotic group (ovalbumin + LK), and control group. Except for the control group, all mice were sensitized with ovalbumin to establish a model of atopic dermatitis. The mixed probiotics were given by gavage for 14 days. Mice body weight, skin lesions, skin inflammation, ovalbumin-specific Ig, the number of Treg and CD103+DC, and the expression level of PD-1/PD-L1 were examined. The results showed that mixed...
Source: International Journal of Microbiology - April 9, 2024 Category: Microbiology Authors: Jinli Huang Xingzhi Wang Qiuhong Li Panpan Zhang Zenghui Jing Juan Zhang Hui Su Xin Sun Source Type: research
Dupilumab in patients with atopic dermatitis: assessing treatment response, clinical features and potential biomarkers in real-life
Conclusions. In this cohort, none of the evaluated biomarkers at baseline were associated with a better/earlier clinical response to dupilumab. Dupilumab treatment for 52 weeks resulted in a significant and sustained reduction in blood levels of total IgE and allergen-specific IgE to aeroallergens. The potential long-term clinical benefit of these effects, even after discontinuing dupilumab therapy in patients with AD, should be explored to a greater extent.PMID:38591168 | DOI:10.23822/EurAnnACI.1764-1489.341 (Source: European Annals of Allergy and Clinical Immunology)
Source: European Annals of Allergy and Clinical Immunology - April 9, 2024 Category: Allergy & Immunology Authors: R Lim ão R Br ás E Pedro S L Silva A Lopes Source Type: research
Amiodarone-Induced Psoriasiform Dermatitis
Ann Pharmacother. 2024 Apr 8:10600280241244511. doi: 10.1177/10600280241244511. Online ahead of print.NO ABSTRACTPMID:38590149 | DOI:10.1177/10600280241244511 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 9, 2024 Category: Drugs & Pharmacology Authors: Myriam Agrebi Dhouha Sahnoun Najet Ghariani Mohamed Denguezli Chaker Ben Salem Source Type: research
